Mr. Fontana et al., IEM101, a naturally attenuated Vibrio cholerae strain as carrier for genetically detoxified derivatives of cholera toxin, VACCINE, 19(1), 2000, pp. 75-85
Two mutants of cholera toxin (CTS106 containing a Pro106 --> Ser substituti
on and CTK63 containing a Ser63 --> Lys substitution) with greatly reduced
or no toxicity respectively, were expressed in the naturally attenuated IEM
101 Vibrio cholerae strain (El Tor, Ogawa) which does not express cholera t
oxin (CT). Expression was driven by the natural promoter of CT, or by a pro
motor known to induce strong in vivo expression such as nirB. In the rabbit
ileal loop assay, where 10(4) wild type bacteria were sufficient to induce
fluid accumulation, 10(9) IEM101 expressing CTS106 bacteria were needed to
induce some fluid accumulation, while IEM101 expressing CTK63 was inactive
, even when 10(10) cells were used. When used to immunize mice intranasally
, all bacteria induced vibriocidal antibodies; however, anti-CT antibodies
were not induced by bacteria expressing low levels of CTK63 under the contr
ol of the ct promoter. Anti-CT antibodies were successfully induced by bact
eria expressing high levels of CTK63 under the control of the nirB promoter
, or by bacteria expressing low levels of CTS106. These data show that anti
bodies against cholera toxin can be induced in vivo by high level expressio
n of a non toxic mutant, or by using a mutant with residual ADP-ribosyltran
sferase activity.
In conclusion, we have shown that IEM101. a naturally attenuated known stra
in known to be safe and immunogenic in humans, can be engineered to express
immunogenic levels of CTK63, and may represent a good candidate for vaccin
ation against cholera, (C) 2000 Elsevier Science Ltd. All rights reserved.